Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine
- PMID: 9249249
- PMCID: PMC1564787
- DOI: 10.1038/sj.bjp.0701226
Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine
Abstract
1. Two types of Ca2+ channel alpha1-subunits were co-expressed in Xenopus oocytes with the Ca2+ channel alpha2- and beta1-subunits. The Ba2+ current through the alpha1C alpha2beta and the alpha1B alpha2beta channels had electrophysiological and pharmacological properties of L- and N-type Ca2+ channels, respectively. 2. Amlodipine had a strong blocking action on both the L-type and N-type Ca2+ channels expressed in the oocyte. The potency of the amlodipine block on the N-type Ca2+ channel was comparable to that on the L-type Ca2+ channel. At -100 mV holding potential, the IC50 values for amlodipine block on the L-type and N-type Ca2+ channel were 2.4 and 5.8 microM, respectively. 3. The blocking action of amlodipine on the N-type Ca2+ channel was dependent on holding potential and extracellular pH, as has been observed with amlodipine block on the L-type Ca2+ channel. A depolarized holding potential and high pH enhanced the blocking action of amlodipine. 4. The time course of block development by amlodipine was similar for L-type and N-type Ca2+ channels. However, it was slower than the time course of block development by nifedipine for the L-type Ca2+ channel.
Similar articles
-
Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).Mol Pharmacol. 1995 Sep;48(3):540-9. Mol Pharmacol. 1995. PMID: 7565636
-
Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.Br J Pharmacol. 1998 Oct;125(3):447-54. doi: 10.1038/sj.bjp.0702092. Br J Pharmacol. 1998. PMID: 9806326 Free PMC article.
-
Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes.J Pharmacol Exp Ther. 1999 Nov;291(2):464-73. J Pharmacol Exp Ther. 1999. PMID: 10525060
-
[Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists].Clin Calcium. 2005 Oct;15(10):1589-97. Clin Calcium. 2005. PMID: 16199903 Review. Japanese.
-
Structural implications in the function of L-type voltage-dependent calcium channels.Gen Physiol Biophys. 1996 Apr;15(2):79-87. Gen Physiol Biophys. 1996. PMID: 8899414 Review.
Cited by
-
Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.Br J Pharmacol. 2004 Dec;143(8):1050-7. doi: 10.1038/sj.bjp.0705944. Epub 2004 Nov 15. Br J Pharmacol. 2004. PMID: 15545287 Free PMC article.
-
Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Mol Pain. 2017 Jan-Dec;13:1744806917714693. doi: 10.1177/1744806917714693. Mol Pain. 2017. PMID: 28580836 Free PMC article.
-
P/Q-type calcium channel modulators.Br J Pharmacol. 2012 Oct;167(4):741-59. doi: 10.1111/j.1476-5381.2012.02069.x. Br J Pharmacol. 2012. PMID: 22670568 Free PMC article. Review.
-
Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update.Intern Emerg Med. 2010 Dec;5(6):469-79. doi: 10.1007/s11739-010-0405-6. Epub 2010 May 18. Intern Emerg Med. 2010. PMID: 20480263 Review.
-
Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.Drugs. 2009;69(1):21-30. doi: 10.2165/00003495-200969010-00002. Drugs. 2009. PMID: 19192934 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous